Skip to content
GenoLensGenoLens

ACO2

Chr 22q13.2

aconitase 2

Aliases:
ACONM
MANE:
ENST00000216254.9

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Ataxia and cerebellar anomalies - narrow panel

    BOTH monoallelic and biallelic, autosomal or pseudoautosomal
  • DDG2P

    BIALLELIC, autosomal or pseudoautosomal
  • Intellectual disability

    BOTH monoallelic and biallelic, autosomal or pseudoautosomal
  • Likely inborn error of metabolism

    BOTH monoallelic and biallelic, autosomal or pseudoautosomal
  • Mitochondrial disorders

    BOTH monoallelic and biallelic, autosomal or pseudoautosomal
  • Optic neuropathy

    BOTH monoallelic and biallelic, autosomal or pseudoautosomal
  • Possible mitochondrial disorder - nuclear genes

    BOTH monoallelic and biallelic, autosomal or pseudoautosomal
  • Retinal disorders

    BOTH monoallelic and biallelic, autosomal or pseudoautosomal

+3 more panels — install the extension to see the full list inline on any page.

Disease associations (Open Targets)

  • infantile cerebellar-retinal degeneration

    0.81
  • optic atrophy 9

    0.69
  • Autosomal dominant optic atrophy, classic type

    0.62
  • optic atrophy

    0.60
  • mitochondrial disease

    0.50
  • hereditary disease

    0.48
  • inborn mitochondrial metabolism disorder

    0.46
  • Retinal dystrophy

    0.40
  • Leber hereditary optic neuropathy

    0.38
  • hereditary optic atrophy

    0.38

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Aconitate hydratase, mitochondrial

Catalyzes the isomerization of citrate to isocitrate via cis-aconitate

Curated MONDO disease pages that list ACO2 among their top associated genes.

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.